Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 2746909, 12 pages
http://dx.doi.org/10.1155/2016/2746909
Review Article

Evidences of Polymorphism Associated with Circadian System and Risk of Pathologies: A Review of the Literature

1Department of Basic Sciences, Universidad del Bío-Bío, Campus Fernando May, 378000 Chillán, Chile
2Group of Biotechnological Sciences, Department of Basic Sciences, Universidad del Bío-Bío, Campus Fernando May, 378000 Chillán, Chile

Received 22 January 2016; Revised 14 April 2016; Accepted 19 April 2016

Academic Editor: Darío A. Castroviejo

Copyright © 2016 F. J. Valenzuela et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Serón-Ferré, M. L. Forcelledo, C. Torres-Farfan et al., “Impact of chronodisruption during primate pregnancy on the maternal and newborn temperature rhythms,” PLoS ONE, vol. 8, no. 2, Article ID e57710, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. F. J. Valenzuela, C. Torres-Farfan, H. G. Richter et al., “Clock gene expression in adult primate suprachiasmatic nuclei and adrenal: is the adrenal a peripheral clock responsive to melatonin?” Endocrinology, vol. 149, no. 4, pp. 1454–1461, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Feng and M. A. Lazar, “Clocks, metabolism, and the epigenome,” Molecular Cell, vol. 47, no. 2, pp. 158–167, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. S. M. Reppert and D. R. Weaver, “Coordination of circadian timing in mammals,” Nature, vol. 418, no. 6901, pp. 935–941, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. L. Dubocovich, P. Delagrange, D. N. Krause, D. Sugden, D. P. Cardinali, and J. Olcese, “International union of basic and clinical pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors,” Pharmacological Reviews, vol. 62, no. 3, pp. 343–380, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. S. Takahashi, H.-K. Hong, C. H. Ko, and E. L. McDearmon, “The genetics of mammalian circadian order and disorder: implications for physiology and disease,” Nature Reviews Genetics, vol. 9, no. 10, pp. 764–775, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Duez and B. Staels, “Rev-erb-α: an integrator of circadian rhythms and metabolism,” Journal of Applied Physiology, vol. 107, no. 6, pp. 1972–1980, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Yin, N. Wu, J. C. Curtin et al., “Rev-erbα, a heme sensor that coordinates metabolic and circadian pathways,” Science, vol. 318, no. 5857, pp. 1786–1789, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Preitner, F. Damiola, Luis-Lopez-Molina et al., “The orphan nuclear receptor REV-ERBα controls circadian transcription within the positive limb of the mammalian circadian oscillator,” Cell, vol. 110, no. 2, pp. 251–260, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. M. Bellet, R. Orozco-Solis, S. Sahar, K. Eckel-Mahan, and P. Sassone-Corsi, “The time of metabolism: NAD+, SIRT1, and the circadian clock,” Cold Spring Harbor Symposia on Quantitative Biology, vol. 76, pp. 31–38, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Li, “SIRT1 and energy metabolism,” Acta Biochimica et Biophysica Sinica, vol. 45, no. 1, pp. 51–60, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Bass, “Circadian topology of metabolism,” Nature, vol. 491, no. 7424, pp. 348–356, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Liu, S. Li, T. Liu, J. Borjigin, and J. D. Lin, “Transcriptional coactivator PGC-1α integrates the mammalian clock and energy metabolism,” Nature, vol. 447, no. 7143, pp. 477–481, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. L. A. Solt, Y. Wang, S. Banerjee et al., “Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists,” Nature, vol. 485, no. 7396, pp. 62–68, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. H. R. Ueda, W. Chen, A. Adachi et al., “A transcription factor response element for gene expression during circadian night,” Nature, vol. 418, no. 6897, pp. 534–539, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Gachon, P. Fonjallaz, F. Damiola et al., “The loss of circadian PAR bZip transcription factors results in epilepsy,” Genes and Development, vol. 18, no. 12, pp. 1397–1412, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. Z. A. Khatib, T. Inaba, M. Valentine, and A. T. Look, “Chromosomal localization and cDNA cloning of the human DBP and TEF genes,” Genomics, vol. 23, no. 2, pp. 344–351, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Frigato, L. Lunghi, M. E. Ferretti, C. Biondi, and C. Bertolucci, “Evidence for circadian rhythms in human trophoblast cell line that persist in hypoxia,” Biochemical and Biophysical Research Communications, vol. 378, no. 1, pp. 108–111, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Torres-Farfan, L. Abarzua-Catalan, F. J. Valenzuela et al., “Cryptochrome 2 expression level is critical for adrenocorticotropin stimulation of cortisol production in the capuchin monkey adrenal,” Endocrinology, vol. 150, no. 6, pp. 2717–2722, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Matsuo, S. Yamaguchi, S. Mitsui, A. Emi, F. Shimoda, and H. Okamura, “Control mechanism of the circadian clock for timing of cell division in vivo,” Science, vol. 302, no. 5643, pp. 255–259, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Fu and N. M. Kettner, “The circadian clock in cancer development and therapy,” Progress in Molecular Biology and Translational Science, vol. 119, pp. 221–282, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Hansen, “Risk of breast cancer after night- and shift work: current evidence and ongoing studies in Denmark,” Cancer Causes and Control, vol. 17, no. 4, pp. 531–537, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. A. Huisman, M. Oklejewicz, A. R. Ahmadi et al., “Colorectal liver metastases with a disrupted circadian rhythm phase shift the peripheral clock in liver and kidney,” International Journal of Cancer, vol. 136, no. 5, pp. 1027–1032, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. A. J. Ditisheim, C. Dibner, J. Philippe, and A. Pechére-Bertschi, “Biological rhythms and preeclampsia,” Frontiers in Endocrinology, vol. 4, article 47, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Mayor, “Shift work is associated with increased risk of type 2 diabetes, study shows,” British Medical Journal, vol. 349, Article ID g4804, 2014. View at Publisher · View at Google Scholar
  26. S. M. W. Rajaratnam, M. E. Howard, and R. R. Grunstein, “Sleep loss and circadian disruption in shift work: health burden and management,” The Medical Journal of Australia, vol. 199, no. 8, pp. S11–S15, 2013. View at Google Scholar · View at Scopus
  27. FastStats, Centers for Disease Control and Prevention (CDC), 2016, http://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm.
  28. J. Boivin, L. Bunting, J. A. Collins, and K. G. Nygren, “International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care,” Human Reproduction, vol. 22, no. 6, pp. 1506–1512, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. D. Nettle and M. Bateson, “The evolutionary origins of mood and its disorders,” Current Biology, vol. 22, no. 17, pp. R712–R721, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Hua, W. Liu, D. Chen et al., “Cry1 and Tef gene polymorphisms are associated with major depressive disorder in the Chinese population,” Journal of Affective Disorders, vol. 157, pp. 100–103, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Hodžić, M. Ristanović, B. Zorn et al., “Genetic variation in circadian rhythm genes CLOCK and ARNTL as risk factor for male infertility,” PLoS ONE, vol. 8, no. 3, Article ID e59220, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Karantanos, G. Theodoropoulos, M. Gazouli et al., “Association of the clock genes polymorphisms with colorectal cancer susceptibility,” Journal of Surgical Oncology, vol. 108, no. 8, pp. 563–567, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. K. I. Pappa, M. Gazouli, E. Anastasiou, Z. Iliodromiti, A. Antsaklis, and N. P. Anagnou, “The major circadian pacemaker ARNT-like protein-1 (BMAL1) is associated with susceptibility to gestational diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 99, no. 2, pp. 151–157, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Blomeyer, A. F. Buchmann, J. Lascorz et al., “Association of PER2 genotype and stressful life events with alcohol drinking in young adults,” PLoS ONE, vol. 8, no. 3, Article ID e59136, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. H. G. Richter, C. Torres-Farfán, P. P. Rojas-García, C. Campino, F. Torrealba, and M. Serón-Ferré, “The circadian timing system: making sense of day/night gene expression,” Biological Research, vol. 37, no. 1, pp. 11–28, 2004. View at Google Scholar · View at Scopus
  36. A. Kalsbeek, S. la Fleur, and E. Fliers, “Circadian control of glucose metabolism,” Molecular Metabolism, vol. 3, no. 4, pp. 372–383, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. L. Chen and G. Yang, “Recent advances in circadian rhythms in cardiovascular system,” Frontiers in Pharmacology, vol. 6, article 71, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Hatanaka, C. Matsubara, J. Myung et al., “Genome-wide profiling of the core clock protein BMAL1 targets reveals a strict relationship with metabolism,” Molecular and Cellular Biology, vol. 30, no. 24, pp. 5636–5648, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. P. L. Huang, “A comprehensive definition for metabolic syndrome,” Disease Models and Mechanisms, vol. 2, no. 5-6, pp. 231–237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Beltrán-Sánchez, M. O. Harhay, M. M. Harhay, and S. McElligott, “Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010,” Journal of the American College of Cardiology, vol. 62, no. 8, pp. 697–703, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. I. Martin-Timon, C. Sevillano-Collantes, A. Segura-Galindo, and F. J. del Canizo-Gomez, “Type 2 diabetes and cardiovascular disease: have all risk factors the same strength?” World Journal of Diabetes, vol. 5, no. 4, pp. 444–470, 2014. View at Google Scholar
  42. D. Lebeche, A. J. Davidoff, and R. J. Hajjar, “Interplay between impaired calcium regulation and insulin signaling abnormalities in diabetic cardiomyopathy,” Nature Clinical Practice Cardiovascular Medicine, vol. 5, no. 11, pp. 715–724, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Westermeier, P. J. Sáez, R. Villalobos-Labra, L. Sobrevia, and M. Farías-Jofré, “Programming of fetal insulin resistance in pregnancies with maternal obesity by ER stress and inflammation,” BioMed Research International, vol. 2014, Article ID 917672, 13 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Nerenberg, S. S. Daskalopoulou, and K. Dasgupta, “Gestational diabetes and hypertensive disorders of pregnancy as vascular risk signals: an overview and grading of the evidence,” Canadian Journal of Cardiology, vol. 30, no. 7, pp. 765–773, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. D. J. Withers, D. J. Burks, H. H. Towery, S. L. Altamuro, C. L. Flint, and M. F. White, “Irs-2 coordinates Igf-1 receptor-mediated β-cell development and peripheral insulin signalling,” Nature Genetics, vol. 23, no. 1, pp. 32–40, 1999. View at Publisher · View at Google Scholar · View at Scopus
  46. P. Cohen, “The twentieth century struggle to decipher insulin signalling,” Nature Reviews Molecular Cell Biology, vol. 7, no. 11, pp. 867–873, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. Y. Gan, C. Yang, X. Tong et al., “Shift work and diabetes mellitus: a meta-analysis of observational studies,” Occupational and Environmental Medicine, vol. 72, no. 1, pp. 72–78, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. N. A. Shamsi, M. D. Salkeld, L. Rattanatray et al., “Metabolic consequences of timed feeding in mice,” Physiology and Behavior, vol. 128, pp. 188–201, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Shostak, J. Meyer-Kovac, and H. Oster, “Circadian regulation of lipid mobilization in white adipose tissues,” Diabetes, vol. 62, no. 7, pp. 2195–2203, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Lee, M.-S. Kim, R. Li et al., “Loss of Bmal1 leads to uncoupling and impaired glucose-stimulated insulin secretion in β-cells,” Islets, vol. 3, no. 6, pp. 381–388, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. B. Marcheva, K. M. Ramsey, E. D. Buhr et al., “Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes,” Nature, vol. 466, no. 7306, pp. 627–631, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. J. M. Carvas, A. Vukolic, G. Yepuri et al., “Period2 gene mutant mice show compromised insulin-mediated endothelial nitric oxide release and altered glucose homeostasis,” Frontiers in Physiology, vol. 3, article 337, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. M. A. Kelly, S. D. Rees, Z. L. Hydriem et al., “Circadian gene variants and susceptibility to type 2 diabetes: a pilot study,” PLoS ONE, vol. 7, no. 4, Article ID e32670, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Renström, R. W. Koivula, T. V. Varga et al., “Season-dependent associations of circadian rhythm-regulating loci (CRY1, CRY2 and MTNR1B) and glucose homeostasis: the GLACIER Study,” Diabetologia, vol. 58, no. 5, pp. 997–1005, 2015. View at Publisher · View at Google Scholar · View at Scopus
  55. P. Y. Woon, P. J. Kaisaki, J. Bragança et al., “Aryl hydrocarbon receptor nuclear translocator-like (BMAL1) is associated with susceptibility to hypertension and type 2 diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 36, pp. 14412–14417, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Yamaguchi, H. Uemura, K. Arisawa et al., “Association between brain-muscle-ARNT-like protein-2 (BMAL2) gene polymorphism and type 2 diabetes mellitus in obese Japanese individuals: a cross-sectional analysis of the Japan Multi-institutional Collaborative Cohort Study,” Diabetes Research and Clinical Practice, vol. 110, no. 3, pp. 301–308, 2015. View at Publisher · View at Google Scholar
  57. R. Karthikeyan, G. Marimuthu, M. Sooriyakumar et al., “Per3 length polymorphism in patients with type 2 diabetes mellitus,” Hormone Molecular Biology and Clinical Investigation, vol. 18, no. 3, pp. 145–149, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. R. Karthikeyan, G. Marimuthu, D. W. Spence et al., “Should we listen to our clock to prevent type 2 diabetes mellitus?” Diabetes Research and Clinical Practice, vol. 106, no. 2, pp. 182–190, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Tsuzaki, K. Kotani, Y. Sano, S. Fujiwara, K. Takahashi, and N. Sakane, “The association of the Clock 3111 T/C SNP with lipids and lipoproteins including small dense low-density lipoprotein: results from the Mima study,” BMC Medical Genetics, vol. 11, article 150, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Uemura, S. Katsuura-Kamano, M. Yamaguchi et al., “Variant of the clock circadian regulator (CLOCK) gene and related haplotypes are associated with the prevalence of type 2 diabetes in the Japanese population,” Journal of Diabetes, 2015. View at Publisher · View at Google Scholar
  61. D. Corella, E. M. Asensio, O. Coltell et al., “CLOCK gene variation is associated with incidence of type-2 diabetes and cardiovascular diseases in type-2 diabetic subjects: dietary modulation in the PREDIMED randomized trial,” Cardiovascular Diabetology, vol. 15, no. 1, article 4, 2016. View at Google Scholar
  62. D. Ye, S. Cai, X. Jiang et al., “Associations of polymorphisms in circadian genes with abdominal obesity in Chinese adult population,” Obesity Research & Clinical Practice, 2016. View at Publisher · View at Google Scholar
  63. F. Gomez-Delgado, A. Garcia-Rios, J. F. Alcala-Diaz et al., “Chronic consumption of a low-fat diet improves cardiometabolic risk factors according to the CLOCK gene in patients with coronary heart disease,” Molecular Nutrition & Food Research, vol. 59, no. 12, pp. 2556–2564, 2015. View at Publisher · View at Google Scholar
  64. H. S. Dashti, J. L. Follis, C. E. Smith et al., “Habitual sleep duration is associated with BMI and macronutrient intake and may be modified by CLOCK genetic variants,” The American Journal of Clinical Nutrition, vol. 101, no. 1, pp. 135–143, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. V. Loria-Kohen, I. Espinosa-Salinas, H. Marcos-Pasero et al., “Polymorphism in the CLOCK gene may influence the effect of fat intake reduction on weight loss,” Nutrition, vol. 32, no. 4, pp. 453–460, 2016. View at Publisher · View at Google Scholar
  66. M. P. Dmitrzak-Weglarz, J. M. Pawlak, M. Maciukiewicz et al., “Clock gene variants differentiate mood disorders,” Molecular Biology Reports, vol. 42, no. 1, pp. 277–288, 2015. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Dallaspezia, C. Lorenzi, A. Pirovano, C. Colombo, E. Smeraldi, and F. Benedetti, “Circadian clock gene Per3 variants influence the postpartum onset of bipolar disorder,” European Psychiatry, vol. 26, no. 3, pp. 138–140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. R. Karthikeyan, G. Marimuthu, C. Ramasubramanian et al., “Association of Per3 length polymorphism with bipolar I disorder and schizophrenia,” Neuropsychiatric Disease and Treatment, vol. 10, pp. 2325–2330, 2014. View at Publisher · View at Google Scholar · View at Scopus
  69. H. A. Mansour, J. Wood, T. Logue et al., “Association study of eight circadian genes with bipolar I disorder, schizoaffective disorder and schizophrenia,” Genes, Brain and Behavior, vol. 5, no. 2, pp. 150–157, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. B. Rajendran and V. N. Janakarajan, “Circadian clock gene aryl hydrocarbon receptor nuclear translocator-like polymorphisms are associated with seasonal affective disorder: an Indian family study,” Indian Journal of Psychiatry, vol. 58, no. 1, pp. 57–60, 2016. View at Publisher · View at Google Scholar
  71. E. M. Byrne, A. C. Heath, P. A. F. Madden et al., “Testing the role of circadian genes in conferring risk for psychiatric disorders,” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, vol. 165, no. 3, pp. 254–260, 2014. View at Publisher · View at Google Scholar · View at Scopus
  72. T. Truong, B. Liquet, F. Menegaux et al., “Breast cancer risk, nightwork, and circadian clock gene polymorphisms,” Endocrine-Related Cancer, vol. 21, no. 4, pp. 629–638, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. A. E. Hoffman, C.-H. Yi, T. Zheng et al., “CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses,” Cancer Research, vol. 70, no. 4, pp. 1459–1468, 2010. View at Publisher · View at Google Scholar · View at Scopus
  74. H. Dai, L. Zhang, M. Cao et al., “The role of polymorphisms in circadian pathway genes in breast tumorigenesis,” Breast Cancer Research and Treatment, vol. 127, no. 2, pp. 531–540, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. M. H. Madden, G. M. Anic, R. C. Thompson et al., “Circadian pathway genes in relation to glioma risk and outcome,” Cancer Causes and Control, vol. 25, no. 1, pp. 25–32, 2014. View at Publisher · View at Google Scholar · View at Scopus
  76. Y. Zhu, R. G. Stevens, A. E. Hoffman et al., “Testing the circadian gene hypothesis in prostate cancer: a population-based case-control study,” Cancer Research, vol. 69, no. 24, pp. 9315–9322, 2009. View at Publisher · View at Google Scholar · View at Scopus
  77. M. D. Wirth, J. B. Burch, J. R. Hébert et al., “Case-control study of breast cancer in India: role of PERIOD3 clock gene length polymorphism and chronotype,” Cancer Investigation, vol. 32, no. 7, pp. 321–329, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Alexander, J. B. Burch, S. E. Steck et al., “Case-control study of the PERIOD3 clock gene length polymorphism and colorectal adenoma formation,” Oncology Reports, vol. 33, no. 2, pp. 935–941, 2015. View at Publisher · View at Google Scholar · View at Scopus
  79. L. W. Chu, Y. Zhu, K. Yu et al., “Variants in circadian genes and prostate cancer risk: a population-based study in China,” Prostate Cancer and Prostatic Diseases, vol. 11, no. 4, pp. 342–348, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. P. Geng, J. Ou, J. Li et al., “Genetic association between PER3 genetic polymorphisms and cancer susceptibility: a meta-analysis,” Medicine, vol. 94, no. 13, article e568, 2015. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Grundy, J. M. Schuetz, A. S. Lai et al., “Shift work, circadian gene variants and risk of breast cancer,” Cancer Epidemiology, vol. 37, no. 5, pp. 606–612, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. Z. Zhang, F. Ma, F. Zhou et al., “Functional polymorphisms of circadian negative feedback regulation genes are associated with clinical outcome in hepatocellular carcinoma patients receiving radical resection,” Medical Oncology, vol. 31, no. 12, p. 179, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. P. Couto, D. Miranda, R. Vieira, A. Vilhena, L. De Marco, and L. Bastos-Rodrigues, “Association between CLOCK, PER3 and CCRN4L with non-small cell lung cancer in Brazilian patients,” Molecular Medicine Reports, vol. 10, no. 1, pp. 435–440, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. S. Zienolddiny, A. Haugen, J.-A. S. Lie, H. Kjuus, K. H. Anmarkrud, and K. Kjærheim, “Analysis of polymorphisms in the circadian-related genes and breast cancer risk in Norwegian nurses working night shifts,” Breast Cancer Research, vol. 15, no. 4, article R53, 2013. View at Publisher · View at Google Scholar · View at Scopus
  85. S. C. Markt, U. A. Valdimarsdottir, I. M. Shui et al., “Circadian clock genes and risk of fatal prostate cancer,” Cancer Causes & Control, vol. 26, no. 1, pp. 25–33, 2015. View at Google Scholar
  86. A. E. Hoffman, T. Zheng, R. G. Stevens et al., “Clock-cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene Cryptochrome 2,” Cancer Research, vol. 69, no. 8, pp. 3605–3613, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. A. Fu, D. Leaderer, T. Zheng, A. E. Hoffman, R. G. Stevens, and Y. Zhu, “Genetic and epigenetic associations of circadian gene TIMELESS and breast cancer risk,” Molecular Carcinogenesis, vol. 51, no. 12, pp. 923–929, 2012. View at Publisher · View at Google Scholar · View at Scopus
  88. K. Hwang, A. N. Yatsenko, C. J. Jorgez et al., “Mendelian genetics of male infertility,” Annals of the New York Academy of Sciences, vol. 1214, pp. E1–E17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  89. M. H. Johnson and M. L. Day, “Egg timers: how is developmental time measured in the early vertebrate embryo?” BioEssays: Biological Timing Mechanisms, vol. 22, no. 1, pp. 57–63, 2000. View at Publisher · View at Google Scholar · View at Scopus
  90. M. J. Boden, T. J. Varcoe, and D. J. Kennaway, “Circadian regulation of reproduction: from gamete to offspring,” Progress in Biophysics and Molecular Biology, vol. 113, no. 3, pp. 387–397, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. A. F. Khattab, F. A. Mustafa, and P. J. Taylor, “The use of urine LH detection kits to time intrauterine insemination with donor sperm,” Human Reproduction, vol. 20, no. 9, pp. 2542–2545, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. J. Zaidi, “Blood flow changes in the intraovarian arteries during the periovulatory period: relationship to the time of day,” Ultrasound in Obstetrics and Gynecology, vol. 7, no. 2, pp. 135–140, 1996. View at Publisher · View at Google Scholar · View at Scopus
  93. J. D. Alvarez, A. Hansen, T. Ord et al., “The circadian clock protein BMAL1 is necessary for fertility and proper testosterone production in mice,” Journal of Biological Rhythms, vol. 23, no. 1, pp. 26–36, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. I. Campos Costa, H. Nogueira Carvalho, and L. Fernandes, “Aging, circadian rhythms and depressive disorders: a review,” American Journal of Neurodegenerative Disease, vol. 2, no. 4, pp. 228–246, 2013. View at Google Scholar
  95. C. A. McClung, “Circadian rhythms and mood regulation: insights from pre-clinical models,” European Neuropsychopharmacology, vol. 21, supplement 4, pp. S683–S693, 2011. View at Publisher · View at Google Scholar
  96. W. P. Witt, T. Deleire, E. W. Hagen et al., “The prevalence and determinants of antepartum mental health problems among women in the USA: a nationally representative population-based study,” Archives of Women's Mental Health, vol. 13, no. 5, pp. 425–437, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. B. L. Parry, C. J. Meliska, D. L. Sorenson et al., “Plasma melatonin circadian rhythm disturbances during pregnancy and postpartum in depressed women and women with personal or family histories of depression,” The American Journal of Psychiatry, vol. 165, no. 12, pp. 1551–1558, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. K. M. Sharkey, T. B. Pearlstein, and M. A. Carskadon, “Circadian phase shifts and mood across the perinatal period in women with a history of major depressive disorder: a preliminary communication,” Journal of Affective Disorders, vol. 150, no. 3, pp. 1103–1108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  99. B. R. Wilsmore, R. R. Grunstein, M. Fransen, M. Woodward, R. Norton, and S. Ameratunga, “Sleep habits, insomnia, and daytime sleepiness in a large and healthy community-based sample of New Zealanders,” Journal of Clinical Sleep Medicine, vol. 9, no. 6, pp. 559–566, 2013. View at Publisher · View at Google Scholar · View at Scopus
  100. A. M. Sangoram, L. Saez, M. P. Antoch et al., “Mammalian circadian autoregulatory loop: a timeless ortholog and mPer1 interact and negatively regulate CLOCK-BMAL1-induced transcription,” Neuron, vol. 21, no. 5, pp. 1101–1113, 1998. View at Publisher · View at Google Scholar · View at Scopus
  101. T. Hunt and P. Sassone-Corsi, “Riding tandem: circadian clocks and the cell cycle,” Cell, vol. 129, no. 3, pp. 461–464, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. Z.-L. Zeng, M.-W. Wu, J. Sun et al., “Effects of the biological clock gene Bmal1 on tumour growth and anti-cancer drug activity,” Journal of Biochemistry, vol. 148, no. 3, pp. 319–326, 2010. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Lee, L. A. Donehower, A. J. Herron, D. D. Moore, and L. Fu, “Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice,” PLoS ONE, vol. 5, no. 6, Article ID e10995, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. K. A. Dyar, S. Ciciliot, L. E. Wright et al., “Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock,” Molecular Metabolism, vol. 3, no. 1, pp. 29–41, 2014. View at Publisher · View at Google Scholar
  105. J. Pflaum, S. Schlosser, and M. Müller, “P53 family and cellular stress responses in cancer,” Frontiers in Oncology, vol. 4, article 285, 2014. View at Publisher · View at Google Scholar · View at Scopus
  106. X. Wang, A. Ji, Y. Zhu et al., “A meta-analysis including dose-response relationship between night shift work and the risk of colorectal cancer,” Oncotarget, vol. 6, no. 28, pp. 25046–25060, 2015. View at Publisher · View at Google Scholar · View at Scopus
  107. B. B. Kamdar, A. I. Tergas, F. J. Mateen, N. H. Bhayani, and J. Oh, “Night-shift work and risk of breast cancer: a systematic review and meta-analysis,” Breast Cancer Research and Treatment, vol. 138, no. 1, pp. 291–301, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. U. Weissbein, N. Benvenisty, and U. Ben-David, “Quality control: genome maintenance in pluripotent stem cells,” Journal of Cell Biology, vol. 204, no. 2, pp. 153–163, 2014. View at Publisher · View at Google Scholar · View at Scopus
  109. H. Murakami and P. Nurse, “DNA replication and damage checkpoints and meiotic cell cycle controls in the fission and budding yeasts,” Biochemical Journal, vol. 349, no. 1, pp. 1–12, 2000. View at Publisher · View at Google Scholar · View at Scopus
  110. G. A. Bjarnason, R. C. K. Jordan, P. A. Wood et al., “Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases,” The American Journal of Pathology, vol. 158, no. 5, pp. 1793–1801, 2001. View at Publisher · View at Google Scholar · View at Scopus
  111. Y. Wang, R. Qian, N. Sun, C. Lu, Z. Chen, and L. Hua, “Circadian gene hClock enhances proliferation and inhibits apoptosis of human colorectal carcinoma cells in vitro and in vivo,” Molecular Medicine Reports, vol. 11, no. 6, pp. 4204–4210, 2015. View at Publisher · View at Google Scholar · View at Scopus
  112. S. K. Chun, S. Chung, H.-D. Kim et al., “A synthetic cryptochrome inhibitor induces anti-proliferative effects and increases chemosensitivity in human breast cancer cells,” Biochemical and Biophysical Research Communications, vol. 467, no. 2, pp. 441–446, 2015. View at Publisher · View at Google Scholar · View at Scopus
  113. S. K. Chun, J. Jang, S. Chung et al., “Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock,” ACS Chemical Biology, vol. 9, no. 3, pp. 703–710, 2014. View at Publisher · View at Google Scholar · View at Scopus
  114. PDQ Adult Treatment Editorial Board, “Adult non-Hodgkin lymphoma treatment (PDQ®): health professional version,” in PDQ Cancer Information Summaries, National Cancer Institute (US), Bethesda, Md, USA, 2002. View at Google Scholar